Skip to content
Recall Observatory FDA recall evidence

Drug product

Nevirapine Extended Release Tablets, 400 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd. Verna Goa, India, Manufactured for: Cipla USA Inc. 9100 S Dadeland Blvd., Suite 1500 Miami, FL 33156, NDC 69097-403-02

D-0382-2019

December 14, 2018

Class II

Product summary

Firm
Cipla Limited
Event
Event 81795
Status
Terminated
Classification
Class II
Quantity
4800 bottles
Official record key
drug-enforcement:D-0382-2019

Official wording

Reason: Failed Dissolution Specifications.

Code information: Lot #: GG80257, Exp. 12/2019

Distribution pattern: Nationwide within the United States

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Dissolution Specifications